Known Medicine
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Known Medicine - overview
Established
2020
Location
Salt Lake City, UT, US
Primary Industry
Biotechnology
About
Based in Utah, US, and established in 2020 by co-founders Andrea Mazzocchi, Ph. D. and Katie-Rose Skelly who are also the company's respective chief executive officer (CEO) and chief technology officer (CTO), Known Medicine operates as a provider of custom micro-tumor platform that intends to help provide new drug for cancer patients. In October 2020, Known Medicine received venture funding from Forward Venture Capital and Kickstart Capital, then later in August 2021, Known Medicine received seed funding led by Caffeinated Capital.
The company engages in creating and providing drug and treatment through oncology diagnostics inference network (ODIN), a purpose-built 3-dimensional (3D) cell culture data set, micro 3D universal support architecture (M3DUSA), a 3D cell culture models, and image representation insight system (IRIS), an analysis pipeline that collects and process data that M3DUSA models provide. Following the investment in August 2021, Known Medicine will partner with its investors to further accelerate the deployment of its organoid technology in partnership with biopharmaceutical companies.
Current Investors
Kickstart, Forward Venture Capital, Khosla Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare IT, Oncology/Cancer Treatment, Medical Software
Website
www.knownmed.com
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Known Medicine - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.